Clinical Utility of Prenatal Whole Exome Sequencing
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 316 participants.
Also called NCT03482141
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase
- Not applicable
- Enrolled
- 316 participants
- Registry
-
NCT03482141
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT03482141. Allocation not applicable; no masking; primary purpose diagnostic. Start 2017-08-01 (actual); primary completion 2022-05-13 (actual). Results posted on 2023-04-14.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Clinical Utility of Prenatal Whole Exome Sequencing
- Acronym
- PWES
- Condition
- Structural Anomalies
- Condition
- Cardiac Anomalies
- Condition
- Central Nervous System Anomalies
- Condition
- Thorax Anomalies
- Condition
- Genito-urinary Anomalies
- Condition
- Gastrointestinal Anomalies
- Condition
- Skeletal Anomalies
- Condition
- Multiple Anomalies
- Intervention (Device)
- Whole Exome Sequencing (WES)
- Lead sponsor
- University of California, San Francisco
Record details
- Record id
cardio:ct-nct03482141- Content hash
54db6b4bfb0c8108f896cb99e5adbb62160536361e58e9c43092b4cc82eb941c